Publicly funded research that yields a patentable innovation is then turned into a private monopoly, as in pharmaceuticals. The public finances the research for its claimed positive externalities, but most of the social benefit is captured via the monopoly, which makes the arrangement even more rentier.

causalpending

Speaker

Michele Boldrin

Evidence Quote

“the most of those are capture via the monopoly thing”

Source

Michele Boldrin on Intellectual Property 05/18/2009— EconTalk
Created: 10/29/2026, 8:30:18 PM

Your notes

Loading notes...